SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-13-002218
Filing Date
2013-11-06
Accepted
2013-11-06 08:06:13
Documents
13
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 942951
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 106352
3 EXHIBIT 10.2 ex10-2.htm EX-10.2 19375
4 EXHIBIT 10.3 ex10-3.htm EX-10.3 11639
5 EXHIBIT 31.1 ex31-1.htm EX-31.1 21055
6 EXHIBIT 31.2 ex31-2.htm EX-31.2 22019
7 EXHIBIT 32.1 ex32-1.htm EX-32.1 8264
  Complete submission text file 0001493152-13-002218.txt   5355088

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE immy-20130930.xml EX-101.INS 683813
9 XBRL SCHEMA FILE immy-20130930.xsd EX-101.SCH 49504
10 XBRL CALCULATION FILE immy-20130930_cal.xml EX-101.CAL 49595
11 XBRL DEFINITION FILE immy-20130930_def.xml EX-101.DEF 151475
12 XBRL LABEL FILE immy-20130930_lab.xml EX-101.LAB 342063
13 XBRL PRESENTATION FILE immy-20130930_pre.xml EX-101.PRE 232561
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 131194735
SIC: 2834 Pharmaceutical Preparations